EMAIL THIS PAGE TO A FRIEND

mAbs

Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.


PMID 25621616

Abstract

Linking the heavy chain (HC) and light chain (LC) genes required for monoclonal antibodies (mAb) production on a single cassette using 2A peptides allows control of LC and HC ratio and reduces non-expressing cells. Four 2A peptides derived from the foot-and-mouth disease virus (F2A), equine rhinitis A virus (E2A), porcine teschovirus-1 (P2A) and Thosea asigna virus (T2A), respectively, were compared for expression of 3 biosimilar IgG1 mAbs in Chinese hamster ovary (CHO) cell lines. HC and LC were linked by different 2A peptides both in the absence and presence of GSG linkers. Insertion of a furin recognition site upstream of 2A allowed removal of 2A residues that would otherwise be attached to the HC. Different 2A peptides exhibited different cleavage efficiencies that correlated to the mAb expression level. The relative cleavage efficiency of each 2A peptide remains similar for expression of different IgG1 mAbs in different CHO cells. While complete cleavage was not observed for any of the 2A peptides, GSG linkers did enhance the cleavage efficiency and thus the mAb expression level. T2A with the GSG linker (GT2A) exhibited the highest cleavage efficiency and mAb expression level. Stably amplified CHO DG44 pools generated using GT2A had titers 357, 416 and 600xa0mg/L for the 3 mAbs in shake flask batch cultures. Incomplete cleavage likely resulted in incorrectly processed mAb species and aggregates, which were removed with a chromatin-directed clarification method and protein A purification. The vector and methods presented provide an easy process beneficial for both mAb development and manufacturing.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D16606
6,9-Diamino-2-ethoxyacridine-DL-lactate monohydrate, 99%
C15H15N3O · C3H6O3 · H2O
93791
Allantoin, analytical standard
C4H6N4O3
A0349000
Allantoin, European Pharmacopoeia (EP) Reference Standard
C4H6N4O3
PHR1364
Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material
C4H6N4O3
05670
Allantoin, ≥98.0% (N)
C4H6N4O3
M1000000
Methotrexate, European Pharmacopoeia (EP) Reference Standard
C20H22N8O5
M7824
Methotrexate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, meets EP, USP testing specifications
C20H22N8O5
PHR1396
Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material
C20H22N8O5
M4010
Methotrexate, meets EP, USP testing specifications
C20H22N8O5 · xH2O
M9929
Methotrexate, meets USP testing specifications
C20H22N8O5 · xH2O
Y0000602
Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard
C20H22N8O5
Y0001668
Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard
C20H22N8O5
M8407
Methotrexate hydrate, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
C20H22N8O5 · xH2O
38364
Phosphate Standard for IC, TraceCERT®, 1000 mg/L phosphate in water
HNa2O4P
P9458
Potassium sulfate, BioXtra, ≥99.0%
K2O4S
RES0797P-A7
Potassium sulfate, PharmaGrade, EP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
K2O4S
P0772
Potassium sulfate, ReagentPlus®, ≥99.0%
K2O4S
P8541
Potassium sulfate, plant cell culture tested
K2O4S
204129
Potassium sulfate, 99.99% trace metals basis
K2O4S
221325
Potassium sulfate, ACS reagent, ≥99.0%, powder or crystals
K2O4S
223492
Potassium sulfate, ACS reagent, ≥99.0%, powder
K2O4S
60528
Potassium sulfate, BioUltra, ≥99.0% (AT)
K2O4S
31270
Potassium sulfate, puriss. p.a., ACS reagent, reag. ISO, ≥99%
K2O4S
12658
Potassium sulfate, meets analytical specification of Ph. Eur., 99-101%
K2O4S
71639
Sodium phosphate dibasic, BioUltra, anhydrous, ≥99.5% (T)
HNa2O4P
71642
Sodium phosphate dibasic, purum p.a., anhydrous, ≥98.0% (T)
HNa2O4P
71496
Sodium phosphate monobasic, purum p.a., anhydrous, ≥99.0% (T)
H2NaO4P
T0376
Thymine, ≥99%
C5H6N2O2
T0895
Thymine, suitable for cell culture, BioReagent
C5H6N2O2
PHR1345
Thymine(Zidovudine Related Compound C), Pharmaceutical Secondary Standard; Certified Reference Material
C5H6N2O2